PL3155011T3 - Mutacje receptora hormonu glikoproteinowego - Google Patents

Mutacje receptora hormonu glikoproteinowego

Info

Publication number
PL3155011T3
PL3155011T3 PL15738404T PL15738404T PL3155011T3 PL 3155011 T3 PL3155011 T3 PL 3155011T3 PL 15738404 T PL15738404 T PL 15738404T PL 15738404 T PL15738404 T PL 15738404T PL 3155011 T3 PL3155011 T3 PL 3155011T3
Authority
PL
Poland
Prior art keywords
hormone receptor
glycoprotein hormone
receptor mutations
mutations
glycoprotein
Prior art date
Application number
PL15738404T
Other languages
English (en)
Inventor
Bernard Rees Smith
Jadwiga Furmaniak
Jane Sanders
Jennifer MILLER-GALLACHER
Original Assignee
Rsr Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rsr Limited filed Critical Rsr Limited
Publication of PL3155011T3 publication Critical patent/PL3155011T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796Receptors; Cell surface antigens; Cell surface determinants for hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/535Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
PL15738404T 2014-06-11 2015-06-11 Mutacje receptora hormonu glikoproteinowego PL3155011T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1410409.5A GB2527286A (en) 2014-06-11 2014-06-11 Glycoprotein hormone receptor mutations
EP15738404.1A EP3155011B1 (en) 2014-06-11 2015-06-11 Glycoprotein hormone receptor mutations
PCT/GB2015/000171 WO2015189543A2 (en) 2014-06-11 2015-06-11 Glycoprotein hormone receptor mutations

Publications (1)

Publication Number Publication Date
PL3155011T3 true PL3155011T3 (pl) 2022-02-28

Family

ID=51267071

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15738404T PL3155011T3 (pl) 2014-06-11 2015-06-11 Mutacje receptora hormonu glikoproteinowego

Country Status (8)

Country Link
US (2) US11732026B2 (pl)
EP (1) EP3155011B1 (pl)
JP (2) JP7223490B2 (pl)
CN (1) CN106573968B (pl)
ES (1) ES2901958T3 (pl)
GB (1) GB2527286A (pl)
PL (1) PL3155011T3 (pl)
WO (1) WO2015189543A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2527286A (en) 2014-06-11 2015-12-23 Rsr Ltd Glycoprotein hormone receptor mutations
BR112019004146A2 (pt) * 2016-08-29 2019-07-09 Inovio Pharmaceuticals Inc composição imunogênica, molécula de ácido nucleico, peptídeo, e, métodos para induzir uma resposta imunológica contra o receptor de hormônio estimulante de folículo e para tratar ou prevenir uma patologia associada a tumor.
KR20200011685A (ko) 2018-07-25 2020-02-04 주식회사유한양행 갑상선 자극 호르몬 수용기(thyrotropin receptor, TSHR) 단편을 포함하는 융합 단백질 및 이의 용도

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909661D0 (en) 1998-06-06 1999-06-23 Rsr Ltd Assays for TSH receptor autoantibodies
US20040132101A1 (en) * 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
EP1565493B1 (en) 2002-11-29 2011-09-21 Rsr Limited Antibody for the thyrotropin receptor and uses thereof
GB0418181D0 (en) 2004-08-13 2004-09-15 Rsr Ltd Thyrotrophin receptor preparations,thyrotrophin receptor epitopes,antibody and hormone interactions therewith,and uses thereof
JP2009529027A (ja) * 2006-03-08 2009-08-13 ビオメトード ヒトインターフェロンガンマ(IFNγ)変異体
US8097699B2 (en) * 2006-08-30 2012-01-17 Rsr Limited Crystal structure of thyroid stimulating hormone receptor
CN101595129B (zh) 2006-08-30 2017-12-08 Rsr有限公司 Thsr受体的晶体结构
US8840891B2 (en) 2007-02-15 2014-09-23 Rsr Limited Human monoclonal antibodies to the thyrotropin receptor which act as antagonists
GB2447786C (en) 2007-03-22 2011-11-09 Heptares Therapeutics Ltd Mutant G-protein coupled receptor proteins and methods for selecting them
US20100249022A1 (en) * 2007-05-18 2010-09-30 University Of Massachusetts Strategy for cloning and expressing the extracellular domains of receptors as soluble proteins
GB0808402D0 (en) * 2008-05-09 2008-06-18 Asterion Ltd Tsh
ES2540538T3 (es) * 2008-12-24 2015-07-10 Rsr Limited Anticuerpos anti-TSHR humanos
US9782454B2 (en) * 2010-04-22 2017-10-10 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
WO2012098413A1 (en) * 2011-01-21 2012-07-26 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
CN108752461A (zh) 2011-02-23 2018-11-06 麻省理工学院 水溶性膜蛋白及其制备和使用方法
US9169309B2 (en) * 2011-03-01 2015-10-27 Humanzyme Inc. Thermostable variants of fibroblast growth factors
CN102344966B (zh) * 2011-10-21 2013-08-07 浙江省疾病预防控制中心 促甲状腺激素受体基因突变位点检测试剂盒、使用方法和应用
GB2527286A (en) 2014-06-11 2015-12-23 Rsr Ltd Glycoprotein hormone receptor mutations

Also Published As

Publication number Publication date
GB2527286A (en) 2015-12-23
US20240043498A1 (en) 2024-02-08
WO2015189543A3 (en) 2016-02-25
WO2015189543A2 (en) 2015-12-17
US11732026B2 (en) 2023-08-22
US20170204159A1 (en) 2017-07-20
JP7223490B2 (ja) 2023-02-16
EP3155011B1 (en) 2021-11-10
JP2022078064A (ja) 2022-05-24
EP3155011A2 (en) 2017-04-19
CN106573968B (zh) 2021-12-21
JP2017520246A (ja) 2017-07-27
ES2901958T3 (es) 2022-03-24
GB201410409D0 (en) 2014-07-23
CN106573968A (zh) 2017-04-19

Similar Documents

Publication Publication Date Title
IL285403A (en) Polypeptides that remove an epitope for mhc of group i
GB201514875D0 (en) Receptor
ZA201605712B (en) Therapeutic combinations with estrogen receptor modulators
HK1252163A1 (zh) 受體
IL249373A0 (en) Polypeptide formulations of related detector and method
SG11201701819PA (en) First entry notification
EP3137272C0 (en) MORTAR DISTRIBUTION SYSTEM
ZA202003023B (en) Benzothiophene-based selective estrogen receptor downregulators
ZA201700342B (en) Novel glp-1 receptor modulators
GB201405337D0 (en) Feed unit
GB201702617D0 (en) Receptor
ZA201608085B (en) Grout delivery
GB201405341D0 (en) Feed unit
EP3350167A4 (en) Androgen receptor Antagonist
PL3155011T3 (pl) Mutacje receptora hormonu glikoproteinowego
GB201405340D0 (en) Feed Unit
PL2902575T3 (pl) System okuciowy
IL252565A0 (en) New receptor modulators
ZA201701071B (en) Modified vip3 polypeptides
GB201701887D0 (en) Receptor
GB201700926D0 (en) Receptor
GB201504285D0 (en) Receptor modulation
GB201405403D0 (en) Receptor modulation
PL2899341T3 (pl) System okuciowy
GB201415235D0 (en) Trans-locating peptide